The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Regression to the mean in progress reports

This is a generated summary. It shows the 5 most-liked posts from a topic of 35, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
HA
h.almeidaTL2Member10 Apr 2025#1

On the subject in the title: Regression to the mean in progress reports Working notes rather than a conclusion.

Something about regression does not reconcile and I would like a second pair of eyes before I decide which half is wrong.

Two sources, both reputable, giving figures that cannot both be right unless they are measuring different quantities. My suspicion is that they are, and I cannot see how.

58 likes 16mo
CO
c.okaforTL3Regular5 Jun 2025#17
Nicolaides, post #9: Reading this regression thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not. Go to post

Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be adjusted for but unknown ones cannot.

If anyone has run this properly I would rather read that than my own guess.

30 likes in reply to #9 14mo
FA
f.abrahamsenTL2Member21 Jun 2025#23

Seconded. It reads as careful rather than confident, which is the right register.

28 likes 13mo
NZ
n.zielinskiTL28 Jul 2025#30

On regression, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.

27 likes 13mo
SC
s.cabreraTL216 Jul 2025#33

Regression to the mean explains a large share of apparent improvements in anything selected for being extreme. It is not a statistical curiosity; it is the default explanation.

The reasoning is more useful than the number, which is why I have shown it.

27 likes 12mo

Read the full topic (35 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
About the Statistics category
Effect sizes, intervals, multiplicity, and the difference between absent and undetected. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
SLJMBVCAV+4 8 2.3k 7mo
Second pass at: Regression to the mean in progress reports
Second pass at: Regression to the mean in progress reports Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Regression. It is mine, it is…
SGCKIAMDM+71 75 4k 17mo
Sample size intuition for a personal experiment
On the subject in the title: Sample size intuition for a personal experiment Working notes rather than a conclusion. A follow-up question about sample size intuition that I did not know to ask the first time.…
RKHECAHTT 4 62k 18mo
Second pass at: Multiplicity when you track fifteen variables
Posting this under the heading it deserves: Second pass at: Multiplicity when you track fifteen variables Everything below is what sits behind that. Two things I would like separated before anyone answers on…
KFFFRM 2 12k 18mo
Absence of evidence and evidence of absence
Absence of evidence and evidence of absence Writing it up because I had to work it out twice and would rather nobody else did. Asking about absence of evidence on behalf of the question I keep seeing asked…
KRFDRNRMHF+16 20 3.9k 5mo

Related topics — sharing the tags number needed to treat, heterogeneity, confounding

TopicParticipantsRepliesViewsActivity
Pooling trials with different estimands
On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion. Asking about pooling trials with different estimands on behalf of the question I keep seeing asked…
RCFCTSRMME+120 132 2.3k 1d
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold?
Asking directly, because I could not find a straight answer: What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold? An honest uncertainty about TRIUMPH rather than a…
DNSLITNCAS+43 47 5.5k just now
Immortal time bias in a claims-database study — one year on
Posting this under the heading it deserves: Immortal time bias in a claims-database study — one year on Everything below is what sits behind that. I would like to disagree carefully with the settled view on…
VMDMMGRPT+41 46 3.7k 22h
Coming back to: Half-life, steady state, and accumulation worked through
On the subject in the title: Half-life, steady state, and accumulation worked through Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the…
CRHKASMISC+14 18 15k 3mo
Gauge and length selection for subcutaneous injection
Gauge and length selection for subcutaneous injection Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about gauge and length selection that I did not…
NVARNSOBHM+50 55 1.3k 8mo